An expert committee headed by NITI Aayog member VK Paul will meet on August 12 to discuss and find a road map on the procurement, distribution and the logistics of Covid-19 vaccine.
Read More
Gland Pharma sells their products primarily under a business to business (“B2B”) model in over 60 countries as of March 31, 2020
Read More
Switzerland will get 4.5 million doses of the vaccine, enough to vaccinate 2.25 million people if as expected two doses are needed per patient.
Read More
Medical Technology Association of India (MTaI), which represents research-based medical technology companies in the country, said the government should consider reducing tax burden on medical devices in order to revive the sector.
Read More
Revenue from operations surged to Rs 668.20 crore during the quarter under review from Rs 611.94 crore in the same period of 2019-20.
Read More
These schemes of the Department of Pharmaceuticals were approved by the Union Cabinet in March this year.
Read More
The Drug Controller General of India granted Cipla accelerated approval to make and sell favipiravir in an effort to meet the "urgent and unmet" need for COVID-19 treatment options in the country
Read More
With the trials of COVID-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, the Serum Institute of India (SII) has said it will apply for license from the Indian regulator to start clinical trials of the shot in a week's time.
Read More
The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations.
Read More
"We urge the administration to fully leverage all authorities including the Defense Production Act and other tools to ensure adequate supplies of remdesivir," the IDSA said.
Read More
